Why these 4 ASX shares have tumbled lower today

The Resapp Health Ltd (ASX:RAP) share price is one of four tumbling lower today. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has put yesterday's decline behind it and carved out a solid 0.4% gain to 5,768 points.

Unfortunately not all shares are climbing higher with the market today. In fact, the four shares listed below have tumbled notably lower.

The Dorsavi Ltd (ASX: DVL) share price has tumbled 14% to 30 cents despite there being no news out of the company behind the ViSafe, ViMove and ViPerform motion analysis products. This latest decline means that DorsaVi's shares have now shed a disappointing 44% of their value year-to-date.

The Mayne Pharma Group Ltd (ASX: MYX) share price has continued to slide lower, this time by 5.5% to 76 cents. The pharmaceutical company's shares have come under heavy selling pressure in the last couple of days after it warned of tough trading conditions in the retail generic drugs channel. Although its shares look to be great value, I would suggest investors hold off an investment until conditions improve.

The Primary Opinion Ltd (ASX: POP) share price has fallen 11% to 2.4 cents a day after its shares rocketed a whopping 80% higher. Yesterday the shares of company which has a 48% interest in the Maggie Beer food products business rocketed higher after it announced that the former CEO of Bellamy's Australia Ltd (ASX: BAL), Laura McBain, would join the company this week as its new managing director.

The Resapp Health Ltd (ASX: RAP) share price has plunged a massive 78% to 7 cents after the digital healthcare company announced the failure of its Smartcough C study results. According to the release, analysis of the study data revealed many issues and the predefined endpoints for positive percent agreement and negative percent agreement with clinical diagnosis are unlikely to be met. Although it looks cheap now, I would caution against buying the dip.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »